{"name":"Center for Health Sciences, Serbia","slug":"center-for-health-sciences-serbia","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":4,"colorKey":"oncology","drugs":[{"name":"TEST 4","genericName":"TEST 4","slug":"test-4","indication":"Other","status":"phase_3"},{"name":"TEST 1","genericName":"TEST 1","slug":"test-1","indication":"Various conditions","status":"marketed"},{"name":"TEST 2","genericName":"TEST 2","slug":"test-2","indication":"Various conditions","status":"marketed"},{"name":"TEST 3","genericName":"TEST 3","slug":"test-3","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"TEST 4","genericName":"TEST 4","slug":"test-4","phase":"phase_3","mechanism":"TEST 4 is a drug that has not been found in available data.","indications":[],"catalyst":""},{"name":"TEST 1","genericName":"TEST 1","slug":"test-1","phase":"marketed","mechanism":"TEST 1 is a medication used to treat various conditions.","indications":["Various conditions"],"catalyst":""},{"name":"TEST 2","genericName":"TEST 2","slug":"test-2","phase":"marketed","mechanism":"TEST 2 is a medication used to treat various conditions.","indications":["Various conditions"],"catalyst":""},{"name":"TEST 3","genericName":"TEST 3","slug":"test-3","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMikwJBVV95cUxNUmNmY1MxeVY2S1dMMWNURTB5N2lZd3MxOEpEUnJUSzZrLVNRUm9PLTAtUE9SY0JuTERiLVhSZDhhUGhqU3VRN2N5bFBzNVRYRTBNbTFhS1B3cndkdnFzNU9QVGxzOXdOVHROM3EwY3M1SUdnWE9JWTYyV2NqWC1fMGptRXZxSUxJVHRJOGh2RGpqM3YzMHp5NnM3OUVfVlpiT2hGZGh2QnNVZHZ0Q2JxbC1BQUNhLTNRaG9DVkNSc3dtQkprY0R1V1VITHRVdUVkVGRPQ2JhQlhMLWs4b0tFdkZhUGdxWmNUWVdsVmVPUkRSS1VBMzZCbmFHQmtTZEU1RVktOVBHSV85bi0yMUROcEh0VQ?oc=5","date":"2026-01-25","type":"pipeline","source":"Daily Republic","summary":"Solano County Business Journal January 2026: Wellness, independence at center of new Vaca pharmacy - Daily Republic","headline":"Solano County Business Journal January 2026: Wellness, independence at center of new Vaca pharmacy","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxOYTBSdXZwUWhWTTU1a0ppbE1STHBuZHYyY0JLLThDZ2RyRnE4UWVNNVlIaWV2aDV4bEFuUF9lcTVKYkM3VjdIM1lTUldYTFJKYUhYYTRzMERYU3BlblNSNWo4bFJTdHFHYXV2X0l5bEl4VmhPVnNOQld0WEQxN2hfNlZhVndWUVpQSXdIYTRhLUZJYVZHVTNvQmw1dTljQVZleVZYRk1OVU9nWkg4dUQ2V1YwRTBrZzNFRVF2TkJ3TUZ5ZUN2MU1iQ1lzNmE0cXlxUXdTb1NuMllFNGR0dkE?oc=5","date":"2025-12-21","type":"pipeline","source":"Williamson Daily News","summary":"Williamson Health and Wellness opens pharmacy downtown - Williamson Daily News","headline":"Williamson Health and Wellness opens pharmacy downtown","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNUmNoV0gzbm1QazN5UjctblJkN2U1dGpLYzJ0dTUxRGNvcHZsOW1zeDBaQUdENWxObWxhMm1vejRKMVFfQ0QtZnZBRXJJRW9heFdvcW9yWC11LXlIOHNRZnRJTUZKbVdqSE9kenh3U2Vic1hEV1lxNWhuYUZXa0ZFSmJZYS11RU1lSV9XWjU5WExQZmJYa1JoZ1E5elBETWNmVE1GWg?oc=5","date":"2025-12-16","type":"deal","source":"PwC","summary":"Pharmaceutical and life sciences: US Deals 2026 outlook: M&A Trends - PwC","headline":"Pharmaceutical and life sciences: US Deals 2026 outlook: M&A Trends","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxNZmpObkxQLXRERk4tWDJoSWdjNHNpWm5aRlNaLUx4MkJValA2bGxrMXlhbHZyeGhMWnJlMElJUXRFVEhNencxaXdLanF3NTByMzAxRGxZV1NWbmxuSWNvdnU1ejMyZXZ1Q2xUMjc3RWZpM0h4ZzFWMEI1b3N3RkRuVktFR1d1d0thajdV?oc=5","date":"2025-11-14","type":"pipeline","source":"Euractiv","summary":"Eli Lilly bets €2.6bn on new Dutch manufacturing hub - Euractiv","headline":"Eli Lilly bets €2.6bn on new Dutch manufacturing hub","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPbThCeGFZSHV5aHhtRDRaQ2RYMnhFSlhaVGtCcDFJSDd4eTJ1NFgtdHcxbXJUWVBiOWFtdUtKSzY2VWNsdUNROTRQRVoyR3pnYTJPck0yNjNwdUg2a0N1Tm9kNWZjakRzWXFQTHVsM0p6VHhRMnlpdzNjckpsdGEzNnhyVE1ZY2JYMGJ3Z0hXamlIT2d0SVNLdWgyQ1VIVVlpOFcyTXNNVnhFMGVBejJUQ2JvOFNjRExRU3ZRckdJR1JVb3l2Q1ZUck5rY1N2UC1STGNjdzk0ME5GVjk2YXFobzdMaw?oc=5","date":"2025-10-30","type":"pipeline","source":"Newark Post","summary":"Specialty medication distribution facility opens near Glasgow - Newark Post","headline":"Specialty medication distribution facility opens near Glasgow","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNWGxIQThZakc3VWloSkRXVzlQR3ZWRUpBeHFGNXZCTGRJaEZxMDJzVHRUUDF5dW9rWFVFQnhzUmdZRXYycXMwTWRrNi04Nl9qTlp0NzZqMTRVMldVbjJVUHQwTXlFMGFVNTRuS2NKS0tyR2MzZDBScWVJZTdNNlJwWmNJOGtjd01LRm9KMmxTSDdlZkt5bXJVblB6ZURZVDdCTmNsd096cmxyaE5FV2JVU0EzSUZmb1dFZ2JlSW5YTHZKTFV6bWtwbA?oc=5","date":"2025-06-18","type":"pipeline","source":"Deloitte","summary":"Measuring the return from pharmaceutical innovation 2024 - Deloitte","headline":"Measuring the return from pharmaceutical innovation 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTE1HanBvS2JpRFYyOF9MSG5mNjdJVnloMVJCNWlxb3ZtczBrM1VrOENpRHdQZy1aWDJMeHM2X0tNWEpQbG9qZVlrYjkzaFRGYkdTa1lZbklabENnSVVaZ1NZ?oc=5","date":"2025-05-07","type":"trial","source":"nature.com","summary":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019 - nature.com","headline":"Characterising acute and chronic care needs: insights from the Global Burden of Disease Study 2019","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPbWxKTFFyX20zN2VBa1k2Sk10Vjh2MHJCc2stUHg0b0dZUTJZZG40REZKTVVQZUpabEpSQjBxelRkLWVnLTZrdWJFNjV5Tlhfam51Sk5lVVhEWVAtTm1yUzMydWF1NUdJeHM2V3hzUGZtemVWS3VOZXlENkVPVjVXeUpzSDdkYUlDbnc4ZkI1WTVJbUpGRUFNT2xTUlNuUnRMejd0OE1ILWRPUQ?oc=5","date":"2025-02-10","type":"pipeline","source":"The University of Arizona Health Sciences","summary":"Janko Nikolich elected to Serbian Academy of Sciences and Arts - The University of Arizona Health Sciences","headline":"Janko Nikolich elected to Serbian Academy of Sciences and Arts","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxObHZGMDJtUVVKd1hqRlhXLVJrZVBwVjRGQk1zQU5GdDRZMDVGbmhVOUFWOWwyUElkSkJ3Ni1ZV21RdS16Q2NMc0g2RWhDQTk1YVBwQXgwLVdRbnZEQkpnNjQxbGxqOWkzX085TGtYc1V0d2h2OHg4VzB4Rmpzckc5YUJ2aG9nXzAycmRGMXdtRmNqM1d5NmhrQnowSWVYNy0zUGFtUWxzcjc1NVdPcWw2TDExSExOVkdibWN4ZG1LTEs3ckczUG5WSXhZbWNkZ2ZQRnZza3pITXhMWERVRjJtYkViMEItTGN6eGpnaHgxUkw5R0E4OWYtbzI2SFRSYnlGNTBXNEtxZXVBQl9Db01iZ2pod0NkdTJmYXB2MVNaZUdSeHd6OGdYQXpSSGltZw?oc=5","date":"2024-06-18","type":"pipeline","source":"Denton Record-Chronicle","summary":"UNT pharmacy school tops state in percentage of students matched with residencies - Denton Record-Chronicle","headline":"UNT pharmacy school tops state in percentage of students matched with residencies - Denton Record","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxQVDdhOUV4UTdhdTNCZ1p4MDRJRUtwSzg1a2NnRW5LVDhlMUdVSy13bjdNYzVSNHV1dk83VmZuYmxCX0lDbmFYT3lLS2lkVGV6RGtWZ3RiXzZiY2ZpM3BuSU5fclRqMFJwUXAxclhYVmlaai1Pbm1yQUhkUmNmY3Z4ZjlUdFlEVTVPRTU4VG9UWUlDVTJaN283NXJCNjZfWEFYR0thTDhWbkJhZVB4SzhaMGh3?oc=5","date":"2024-02-20","type":"pipeline","source":"Population Council","summary":"The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipurpose Intravaginal Ring - Population Council","headline":"The Population Council’s Center for Biomedical Research Enters Agreement with Exeltis to Develop a Non-Hormonal Multipur","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikwFBVV95cUxNLVJnS0hDLUw2QXlkUGREMEsxaDN2RTZ0aFA5NDJsRDRPS1lGVFdIM1lpbTh0a0F2dC1EOEhROEdiWXZuMTRBT0lEb0ktZ2UtTWxjblFnaXZBbmhkMXhJdThWcUZqa2d6SmY3T2R6ZDRHVi00WUFTZ1Y3ekdBTHJYOGFtWFJPX2pTLTE3YlgtTUhlX2M?oc=5","date":"2024-02-15","type":"pipeline","source":"Frontiers","summary":"Dynamics of Health Care Financing and Spending in Serbia in the XXI Century - Frontiers","headline":"Dynamics of Health Care Financing and Spending in Serbia in the XXI Century","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAFBVV95cUxPWDZxb3VOajRDcll1aWNTNW4xVlRUbktJNUhzVi1Pc3pic3FIWnZubTdQNXZiY3BSQmV2UTQ0RjdZbGdHRlIxalJ5NS1oT0ZUYWMtZDRobzBpc3BQc3J0el9IX3JhdndpUktNSFFHVnZfcnJKdElqVF81anVIVmc3Sko2VkhJajV6ZWlROF9yOEM?oc=5","date":"2020-08-16","type":"trial","source":"appliedclinicaltrialsonline.com","summary":"Clinical Trials in Serbia: From Strong to Stronger - appliedclinicaltrialsonline.com","headline":"Clinical Trials in Serbia: From Strong to Stronger","sentiment":"neutral"}],"patents":[],"drugCount":4,"phaseCounts":{"phase_3":1,"marketed":3},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}